Memorial Hermann Health System: Researchers Find Mobile Stroke Units Improve Outcomes and Reduce Disability Among Stroke Patients
March 18, 2021
March 18, 2021
HOUSTON, Texas, March 18 -- Memorial Hermann Health System issued the following news release on March 17, 2021:
Patients received the clot-busting medication tissue plasminogen activator (tPA) faster, more often and recovered significantly better when treated via a mobile stroke unit (MSU) compared to standard management by Emergency Medical Services (EMS), according to research announced today at the International Stroke Conference.
The research was led by James Grotta . . .
Patients received the clot-busting medication tissue plasminogen activator (tPA) faster, more often and recovered significantly better when treated via a mobile stroke unit (MSU) compared to standard management by Emergency Medical Services (EMS), according to research announced today at the International Stroke Conference.
The research was led by James Grotta . . .